Literature DB >> 1660972

Receptor-selective analogs demonstrate NPY/PYY receptor heterogeneity in rat brain.

S A Aicher1, M Springston, S B Berger, D J Reis, C Wahlestedt.   

Abstract

Neuropeptide Y (NPY) receptors are heterogeneous, consisting of at least two subclasses, Y1 and Y2. We sought evidence for differential expression of NPY receptor subtypes in the rat brain. Tissue was incubated with 125I-peptide YY (PYY) which labels NPY and PYY binding sites. The Y1-selective agonist, p[Pro34]NPY, and the Y2-selective agonist, pNPY 13-36, were used as displacing ligands. Autoradiographic analyses of regional receptor binding demonstrated heterogeneity across brain regions. We conclude that Y1- and Y2-receptors may be independently expressed in the brain. While the predominate NPY/PYY receptor subtype in the brain is Y2, there are also Y1-receptors in some brain regions such as the superficial layers of the parietal cortex.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660972     DOI: 10.1016/0304-3940(91)90220-n

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  [(125)I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y(1) and Y(4) receptors.

Authors:  Y Dumont; R Quirion
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

2.  Neuropeptide Y-like substances are released from the rostral brainstem of cats during the muscle pressor response.

Authors:  C A Williams
Journal:  J Physiol       Date:  1996-08-15       Impact factor: 5.182

3.  Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro.

Authors:  S Greber; C Schwarzer; G Sperk
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

4.  Functional effects and ligand binding of chimeric galanin-neuropeptide Y (NPY) peptides on NPY and galanin receptor types.

Authors:  U Kahl; U Langel; T Bartfai; L Grundemar
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

5.  Neuropeptide Y potentiates via Y2-receptors the inhibitory effect of noradrenaline in rat locus coeruleus neurones.

Authors:  P Illes; E P Finta; K Nieber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

6.  Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.

Authors:  M Gué; J L Junien; J R Reeve; J Rivier; D Grandt; Y Taché
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

7.  Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain.

Authors:  Y Dumont; A Fournier; R Quirion
Journal:  J Neurosci       Date:  1998-08-01       Impact factor: 6.167

Review 8.  Neuropeptide Y in Alcohol Addiction and Affective Disorders.

Authors:  Annika Thorsell; Aleksander A Mathé
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-31       Impact factor: 5.555

Review 9.  NPY and Gene Therapy for Epilepsy: How, When,... and Y.

Authors:  Stefano Cattaneo; Gianluca Verlengia; Pietro Marino; Michele Simonato; Barbara Bettegazzi
Journal:  Front Mol Neurosci       Date:  2021-01-22       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.